» Articles » PMID: 9820449

Higher Risk for Renal Failure in First-degree Relatives of White Patients with End-stage Renal Disease: a Population-based Study

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 1998 Nov 20
PMID 9820449
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the possibility that hereditary factors increase the risk for end-stage renal disease (ESRD), 669 patients with ESRD in the province of Newfoundland, Canada from 1987 to 1993 were studied. Detailed family histories were obtained from 584 (87%) consecutive probands and 499 spousal control subjects. Diseases with a Mendelian pattern of inheritance accounted for 8.4% of the cases; 4.5% of the cases were caused by autosomal dominant polycystic kidney disease (ADPKD). Glomerulonephritis was the original cause of renal failure in 25% of the probands, diabetes mellitus (DM) in 20%, unknown in 14%, interstitial kidney disease in 11%, other disease in 12%, multifactorial in 4%, and hypertension in 5%. In the group without a Mendelian pattern of inheritance, 28% of the probands had a first-, second-, or third-degree relative with renal failure associated with death or dialysis versus 15% of the controls. Compared with 0.4% of the control group, 1.2% of the first-degree relatives of probands developed renal failure (odds ratio [OR]=3.0; 95% confidence interval [CI], 1.7 to 5.2). No difference was observed when risks were compared for second-degree relatives, but a highly significant increased risk was observed for third-degree relatives (OR=2.1; 95% CI, 1.2 to 3.4). The highest rates of affected first-degree relatives occurred in probands with hypertensive renal failure (2.3%), DM (1.6%), and interstitial kidney disease (1.6%). The annual provincial incidence of ESRD, registered with the Canadian Organ Replacement Registry (CORR) from 1981 to 1993 was 79 per million, excluding the 8% of patients with Mendelian inherited disease. The similar rate of ESRD in first-degree relatives of probands without Mendelian inherited disease was 297 per million. We conclude that not only is the contribution of Mendelian inherited diseases to ESRD high, but there is also an increased risk for renal failure in first-degree relatives of probands without a Mendelian inherited renal disease in a white population.

Citing Articles

A pragmatic approach to selective genetic testing in kidney transplant candidates.

Nissaisorakarn P, Fadakar P, Safa K, Lundquist A, Riella C, Riella L Front Transplant. 2024; 2:1342471.

PMID: 38993907 PMC: 11235289. DOI: 10.3389/frtra.2023.1342471.


The Minnesota attributable risk of kidney donation (MARKD) study: a retrospective cohort study of long-term (> 50 year) outcomes after kidney donation compared to well-matched healthy controls.

Vock D, Helgeson E, Mullan A, Issa N, Sanka S, Saiki A BMC Nephrol. 2023; 24(1):121.

PMID: 37127560 PMC: 10152793. DOI: 10.1186/s12882-023-03149-7.


Association between familial aggregation of chronic kidney disease and its incidence and progression.

Kim J, Chun S, Lim H, Chang T Sci Rep. 2023; 13(1):5131.

PMID: 36991140 PMC: 10060248. DOI: 10.1038/s41598-023-32362-5.


The Living Kidney Donor Safety Study: Protocol of a Prospective Cohort Study.

Garg A, Arnold J, Cuerden M, Dipchand C, Feldman L, Gill J Can J Kidney Health Dis. 2022; 9:20543581221129442.

PMID: 36325263 PMC: 9619271. DOI: 10.1177/20543581221129442.


Long-term Medical Outcomes of Living Kidney Donors.

Matas A, Rule A Mayo Clin Proc. 2022; 97(11):2107-2122.

PMID: 36216599 PMC: 9747133. DOI: 10.1016/j.mayocp.2022.06.013.